LifeLock and Arthritis Foundation announce new partnership deal

With identity theft complaints reaching a 5-year high, and the cost to consumers increasing, the longer the fraud goes undetected, according to Javelin Strategy & Research, the urgency to guard against this crime has increased as well. Through a new partnership announced today between LifeLock, Inc., a leader in identity theft protection services, and the Arthritis Foundation, Foundation members can now receive LifeLock’s services at a special discounted rate.

Over 46 million adults are affected by arthritis, making it the most common cause of disability in the United States, according to the Arthritis Foundation. For arthritis sufferers stress relief is a major priority.

According to the 2009 Javelin Identity Fraud Survey Report, the number of identity fraud victims increased 22% to 9.9 million adults in 2008. The report found that the total annual cost of identity fraud to Americans last year was $48 billion. This partnership makes LifeLock’s services more accessible to Arthritis Foundation members through the reduced cost.

“The partnership will allow LifeLock to better support people with arthritis from becoming victims of identity theft,” said Steve McGrady, LifeLock Vice President of Partner Sales. “We are continuously looking for innovative ways to educate consumers on the dangers of identity theft, and this new partnership allows us to reach folks who can particularly benefit from what we do.”

“The Arthritis Foundation appreciates this exciting new relationship with LifeLock, and we are proud that the company recognizes the importance of our mission,” said Scott Walters, Group Vice President Corporate Relations Arthritis Foundation.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Steritas' Pediatric Glucocorticoid Toxicity Index applied in clinical trial to assess steroid-toxicity